Literature DB >> 19680823

Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.

Sharon Mexal1, Ralph Berger, Judy Logel, Randal G Ross, Robert Freedman, Sherry Leonard.   

Abstract

The alpha7 neuronal nicotinic receptor gene (CHRNA7) has been implicated in the pathophysiology of schizophrenia by genetic and pharmacological studies. Expression of the alpha7* receptor, as measured by [(125)I]alpha-bungarotoxin autoradiography, is decreased in postmortem brain of schizophrenic subjects compared to non-mentally ill controls. Most schizophrenic patients are heavy smokers, with high levels of serum cotinine. Smoking changes the expression of multiple genes and differentially regulates gene expression in schizophrenic hippocampus. We examined the effects of smoking on CHRNA7 expression in the same tissue and find that smoking differentially regulates expression of both mRNA and protein for this gene. CHRNA7 mRNA and protein levels are significantly lower in schizophrenic nonsmokers compared to control nonsmokers and are brought to control levels in schizophrenic smokers. Sufficient protein but low surface expression of the alpha7* receptor, seen in the autoradiographic studies, suggests aberrant assembly or trafficking of the receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680823      PMCID: PMC2808436          DOI: 10.1007/s12031-009-9233-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  82 in total

1.  Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+.

Authors:  S Vijayaraghavan; P C Pugh; Z W Zhang; M M Rathouz; D K Berg
Journal:  Neuron       Date:  1992-02       Impact factor: 17.173

2.  Assembly of nicotinic alpha7 subunits in Xenopus oocytes is partially blocked at the tetramer level.

Authors:  Annette Nicke; Heike Thurau; Sven Sadtler; Jürgen Rettinger; Günther Schmalzing
Journal:  FEBS Lett       Date:  2004-09-24       Impact factor: 4.124

3.  Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.

Authors:  E Cooper; S Couturier; M Ballivet
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

4.  Regulation of nicotinic receptor expression by the ubiquitin-proteasome system.

Authors:  John C Christianson; William N Green
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

5.  Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.

Authors:  Vincenzo De Luca; Albert H C Wong; Daniel J Muller; Gregory W H Wong; Rachel F Tyndale; James L Kennedy
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

6.  Eye-tracking patterns in schizophrenia.

Authors:  P S Holzman; L R Proctor; D W Hughes
Journal:  Science       Date:  1973-07-13       Impact factor: 47.728

7.  Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

8.  alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain.

Authors:  S Wonnacott
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

9.  Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.

Authors:  S Grady; M J Marks; S Wonnacott; A C Collins
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

10.  BIP associates with newly synthesized subunits of the mouse muscle nicotinic receptor.

Authors:  P Blount; J P Merlie
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more
  42 in total

1.  Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.

Authors:  Christian Luckhaus; Uwe Henning; Stefano Ferrea; Francesco Musso; Arian Mobascher; Georg Winterer
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

Review 2.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

4.  Admixture mapping of lung cancer in 1812 African-Americans.

Authors:  Ann G Schwartz; Angela S Wenzlaff; Cathryn H Bock; Julie J Ruterbusch; Wei Chen; Michele L Cote; Amanda S Artis; Alison L Van Dyke; Susan J Land; Curtis C Harris; Sharon R Pine; Margaret R Spitz; Christopher I Amos; Albert M Levin; Paul M McKeigue
Journal:  Carcinogenesis       Date:  2010-11-29       Impact factor: 4.944

5.  Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex.

Authors:  Yang Yang; Constantinos D Paspalas; Lu E Jin; Marina R Picciotto; Amy F T Arnsten; Min Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

6.  Nicotinic modulation of salience network connectivity and centrality in schizophrenia.

Authors:  Jason Smucny; Korey P Wylie; Eugene Kronberg; Kristina T Legget; Jason R Tregellas
Journal:  J Psychiatr Res       Date:  2017-02-03       Impact factor: 4.791

7.  Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Authors:  Kenneth A Perkins; K N Roy Chengappa; Joshua L Karelitz; Margaret C Boldry; Valerie Michael; Taylor Herb; Jessica Gannon; Jaspreet Brar; Lisa Ford; Stefanie Rassnick; Darlene H Brunzell
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

8.  The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.

Authors:  Tanguy Araud; Sharon Graw; Ralph Berger; Michael Lee; Estele Neveu; Daniel Bertrand; Sherry Leonard
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

Review 9.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

Review 10.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.